Four genetic tumor markers specific for human glioblastoma

Details Four genetic tumor markers specific for human glioblastoma Four genetic tumor markers specific for human glioblastoma

2006-10-03

2006-10-03

Yaen, Christopher (Department: 1643)

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

C424S181100

Reexamination Certificate

active

07115265

ABSTRACT:
ABCC3, GPNMB, NNMT, and SEC61γ are expressed at higher levels in glioblastoma than in normal brain tissue. These four genes and their expression products are useful for diagnosing and treating glioblastoma and for identifying potential anticancer drugs.

REFERENCES:
patent: 5352447 (1994-10-01), Johnson et al.
patent: 5403574 (1995-04-01), Piwnica-Worms
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 6025473 (2000-02-01), Deeley et al.
patent: 6063621 (2000-05-01), Deeley et al.
patent: 6080842 (2000-06-01), Hillman et al.
Braun et al (Genes Dev Jun. 1989;3(6):793-802).
Lazarus LH et al (J. Neurosci. Methods Mar. 1998;23(2):161-72).
Reiter et al (Clin Cancer Res Feb. 1996;2(2):245-52).
Maynard et al (Annu. Rev Biomed Eng 2000;2:339-76).
Curti (Clinical Reviews in Oncology/Hematology 1993;14:29-39).
Jain (Science 1996; 271:1079-1080).
Sirotnak, F.M., et al, “Co-administration of Probenecid, an Inhibitor of a cMOAT/MRP-like Plasma Membrane ATPase, Greatly Enhanced the Efficacy of a New 10-Deazaaminopterin against Human Solid tumorsin Vivo1”, Clinical Cancer Research, vol. 6, 3705-3712, Sep. 2000.
Demolombe, Sophie, et al, “ATP-binding cassette proteins as targets for drug discovery”, Trends in Pharmacy Science, vol. 17, pp. 273-275, Aug. 1996.
Scheffer, George L., et al, “Specific Detection of Multidrug Resistance Proteins MFP1, MRP2, MRP3, MRP5, And MDR3, P-Glycoprotein with a Panel of Monoclonal Antibodies1”, Cancer Research 60, pp. 5269-5277, Sep. 15, 2000.
Moody, T.W., et. al, “Neuromedin B-Like Peptides in Rat Brain: Biochemical Characterization, Mechanism of Release and Localization in Synaptosomes”, Peptides, vol. 7, pp. 815-820, Mar. 1986.
Lazarus, L.H., et al, “Assessment of Neuromedin B Polyclonal antibodies as molecular probes in neural tissue”, Journal of Neuroscience Methods, 23 pp. 161-172 (1988).
Siegfried, J.M, et al, “Evidence for Autocrine Actions of Neuromedin B and Gastrin-releasing Peptide in Non-small Cell Lung Cancer”, Pulmonary Pharmacology & Therapeutics, vol. 12, pp. 291-302, (1999).
Hamazaki, H., “Neuromedin B”, Progress in Neurobiology 62 pp. 297-312, (2000).
Kiaris, H. et. al. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide, Oncogene 18, pp. 7168-7173, (1999).
Aksoy, S. et al “Human Nicotinamide N-Methyltransferase Gene: Molecular Cloning, Structural Characterization and Chromosomal Localization”, Genomics 29, pp. 555-561 (1995).
Sano, Akira. et. al “Fluorometric Assay of Rat Tissue N-Methyltransferases with Nicotinamide and Four Isomeric Methylnicotinamides”, Chem. Pharm. Bull. 40 (1) pp. 153-156 (1992).
Rini, Josephine, “Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation”, Clinica Chimica Acta, 186 pp. 359-374, (1989).
Greenfield, Julia, et. al. “The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment” Journal of Cell Science 112, 1477-1486 (1999).
Wiertz, Emmanuel, et. al. “Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction”, Nature, vol. 384, Dec. 5, 1996.
Weterman, Marian, et al.,“A Novel Gene Is Expressed In Low-Metastatic Human Melanoma Cell Lines And Xenografts” Int. J. Cancer 60, pp. 73-81 (1995).
Ashley, D. et al., “Bone Marrow-Generated Dendritic Cells Pulsed With Tumor Extracts Or Tumor RNA Induce Antitumor Immunity Against Central Nervous System Tumors”, J. Exp. Med., vol. 186, No. 7, pp. 1177-1182 (1997).
Loging, W.T., et al., “Identifying Potential Tumor Markers And Antigens By Database Mining And Rapid Expression Screening”, Genome Res., vol. 10, No. 9, Abstract (2000).

Affiliated with

Also associated with

Rating

Four genetic tumor markers specific for human glioblastoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Four genetic tumor markers specific for human glioblastoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Four genetic tumor markers specific for human glioblastoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3648641